Page 278 - EJMO-9-2
P. 278

Eurasian Journal of Medicine

                                                                                    and Oncology




                                        ORIGINAL RESEARCH ARTICLE
                                        Network pharmacology and bioinformatics

                                        reveal the multi-target mechanisms of the
                                        Qiang-gu-jian-shen formula osteoporosis

                                        treatment



                                        Cuicui Zhou , Zarina Awang , and Farra Aidah Jumuddin *
                                                  1,2
                                                                 1
                                                                                          1
                                        1 Department of Clinical Medicine, Faculty of Medicine, Lincoln University College, Petaling Jaya,
                                        Selangor, Malaysia
                                        2 Department  of Orthopaedic  Surgery,  The  Second  Affiliated  Hospital of  Nanyang Medical  College,
                                        Nanyang, Henan, China
                                        Abstract

                                        Osteoporosis (OP) is a systemic skeletal disease characterized by reduced bone mass and
                                        deteriorated bone microstructure, significantly increasing fracture risk. As global aging
                                        intensifies, OP has become a significant public health issue. Present pharmacological
                                        interventions, such as bisphosphonates and selective estrogen receptor modulators,
                                        are associated with side effects and limitations, highlighting the need for safe and
                                        effective alternatives. This study investigates the potential mechanisms of the Qiang-
                                        gu-jian-shen formula (QGJSF), a traditional Chinese medicine (TCM) compound,
            *Corresponding author:      in treating OP using network pharmacology and bioinformatics. A  total of 1,395
            Farra Aidah Jumuddin        potential targets for QGJSF were identified by querying the TCMSP and BATMAN-TCM
            (farraaiadah@lincoln.edu.my)  databases and converting targets through UniProt. Cross-referencing with OP-related
            Citation: Zhou C, Awang Z,   targets from GeneCards, OMIM, and DisGeNET yielded 500 mapped targets. Protein-
            Jumuddin FA. Network        protein interaction network constructed through the STRING database led to the
            pharmacology and bioinformatics
            reveal the multi-target mechanisms   identification of 69 core targets. An “herb-active component-target” network was built
            of Qiang-gu-jian-shen formula   using Cytoscape 3.9.0. Gene ontology functional annotation and Kyoto Encyclopedia
            osteoporosis treatment. Eurasian J   of Genes and Genomes pathway enrichment analyses highlighted key pathways,
            Med Oncol. 2025;9(2):270-284.
            doi: 10.36922/EJMO025150103  including the PI3K/AKT and FoxO. Molecular docking showed that key components,
                                        such as quercetin, dioscin, genistein, calycosin, and berberine, bind favorably to core
            Received: April 10, 2025    targets (binding energies < −5 kcal/mol). GEO dataset (GSE5958) analysis identified
            Revised: May 13, 2025       seven common core genes, including TGFB1, MMP2, BCL2L1, MAPK3, AKT1, CTNNB1,
            Accepted: May 14, 2025      and  TP53.  The findings suggest that QGJSF may improve OP through multiple
                                        components that regulate osteoblast differentiation, osteoclastogenesis, and activate
            Published online: June 18, 2025  key pathways, such as Wnt/β-catenin, PI3K/AKT, and JAK/STAT, thereby enhancing
            Copyright: © 2025 Author(s).   bone formation and reducing resorption. Core targets such as ESR1, STAT3, AKT1, and
            This is an Open-Access article   TP53 regulate  bone metabolism by  modulating osteoblasts, osteoclasts, and  their
            distributed under the terms of the
            Creative Commons Attribution   interactions with immune and hematopoietic cells to maintain bone remodeling. This
            License, permitting distribution,   study advances understanding of QGJSF’s mechanisms and provides a foundation
            and reproduction in any medium,   for novel OP therapies. Future validation and exploration of additional therapeutic
            provided the original work is
            properly cited.             targets and mechanisms are needed.
            Publisher’s Note: AccScience
            Publishing remains neutral with   Keywords: Qiang-gu-jian-shen formula; Osteoporosis; Network pharmacology;
            regard to jurisdictional claims in
            published maps and institutional   Mechanisms
            affiliations.




            Volume 9 Issue 2 (2025)                        270                         doi: 10.36922/EJMO025150103
   273   274   275   276   277   278   279   280   281   282   283